Transcode Therapeutics News

Transcode Therapeutics | DEF 14A: Definitive information statements

Apr 29 16:09 ET

Transcode Therapeutics | 8-K: Current report

Apr 23 16:06 ET

Transcode Therapeutics | 8-K: Current report

Apr 5 16:55 ET

Transcode Therapeutics | 8-K: Current report

Jan 31 16:39 ET

Transcode Therapeutics | 8-K: Current report

Jan 22 00:00 ET

Transcode Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 18 00:00 ET

Transcode Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 17 00:00 ET

Transcode Therapeutics | 8-K: Current report

Jan 16 00:00 ET

Transcode Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Jan 11 00:00 ET

Transcode Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Transcode Therapeutics | DEFA14A: Others

Jan 4 00:00 ET

Transcode Therapeutics | DEF 14A: Definitive information statements

Dec 18, 2023 16:28 ET

Transcode Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 8, 2023 16:57 ET

Transcode Therapeutics | 8-K: Current report

Dec 8, 2023 16:56 ET

Transcode Therapeutics | 8-K: Current report

Dec 4, 2023 17:07 ET

Transcode Therapeutics | 8-K: TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update

Nov 14, 2023 16:40 ET

Transcode Therapeutics | 8-K: Current report

Nov 9, 2023 16:13 ET

Transcode Therapeutics | 8-K: Current report

Oct 27, 2023 16:06 ET

Transcode Therapeutics | 8-K: Current report

Oct 24, 2023 08:05 ET

Transcode Therapeutics | 8-K: Current report

Sep 28, 2023 16:07 ET